[1]
2021. Novel hormonal agents for metastatic Castration-Resistant Prostate Cancer: comparing outcomes. A single-center retrospective study. Archivio Italiano di Urologia e Andrologia. 93, 4 (Dec. 2021), 393–398. DOI:https://doi.org/10.4081/aiua.2021.4.393.